You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Go to Close Top

Please see below the educational materials available to Healthcare Professionals in Ireland:

Information for Patients (Patient Card) (May 2019)

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority,
Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie . Adverse events should also be reported to GlaxoSmithKline on
1800 244 255.

Volibris is a registered trademark of Gilead, used under licence by the GlaxoSmithKline Group of Companies.